Free Trial

Jupiter Asset Management Ltd. Trims Holdings in Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies logo with Medical background
Remove Ads

Jupiter Asset Management Ltd. trimmed its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 10.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,645 shares of the medical research company's stock after selling 49,450 shares during the quarter. Jupiter Asset Management Ltd. owned about 0.14% of Agilent Technologies worth $54,763,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. CKW Financial Group grew its holdings in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after acquiring an additional 100 shares during the period. Global X Japan Co. Ltd. grew its holdings in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares during the period. Ashton Thomas Securities LLC acquired a new stake in Agilent Technologies during the third quarter worth about $31,000. Hanson & Doremus Investment Management grew its holdings in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after acquiring an additional 105 shares during the period. Finally, OFI Invest Asset Management acquired a new stake in Agilent Technologies during the fourth quarter worth about $37,000.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $121.15 on Wednesday. Agilent Technologies, Inc. has a one year low of $119.30 and a one year high of $155.35. The company has a market cap of $34.54 billion, a price-to-earnings ratio of 27.85, a PEG ratio of 3.42 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The business's 50 day moving average price is $139.16 and its 200 day moving average price is $138.41.

Remove Ads

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. On average, research analysts predict that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.82%. Agilent Technologies's dividend payout ratio is currently 22.76%.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the company a "buy" rating in a report on Thursday, December 19th. Bank of America dropped their price objective on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a report on Friday, December 13th. JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Tuesday, November 26th. Wells Fargo & Company dropped their price objective on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a report on Monday, December 9th. Finally, StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $146.15.

Check Out Our Latest Stock Report on Agilent Technologies

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Further Reading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY NOW in March 2025

5 Stocks to BUY NOW in March 2025

MarketBeat's Thomas Hughes looks at five stocks poised for gains this year that investors should have on their watchlists for buying opportunities in March.

Related Videos

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads